# Venlafaxine as Adjunct Therapy in Rheumatoid Arthritis

> **NCT07497282** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Ain Shams University** · enrollment: 70 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** venlafaxine extended-release (XR)
- **OTHER:** Standard conventional Rheumatoid Arthritis Therapy

## Key facts

- **NCT ID:** NCT07497282
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-26
- **Primary completion:** 2026-10-26
- **Final completion:** 2026-12-26
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07497282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07497282, "Venlafaxine as Adjunct Therapy in Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07497282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*